News about Biotechnology, Pharmaceutical and Healthcare

01:20 EDT 21st October 2014 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 9,200+

Monday 20th October 2014

Shaking up cell biology

Researchers focus in on decades old mystery.

Developing Insulin-Producing Cells to Treat Diabetes

Researchers transformed human stem cells into pancreatic beta cells that produce insulin and respond to glucose. The finding could lead to new therapies to treat diabetes.

Progress Toward an H7N9 Avian Flu Vaccine

An experimental vaccine against H7N9 avian influenza prompted substantial immune responses in 59% of volunteers. The approach could lead to improved flu vaccines.

Targeting Health Risks in Early Stages of Schizophrenia

Certain heart-related risk factors are present early in people diagnosed with schizophrenia spectrum disorders. The findings highlight early treatment opportunities.

Medicine Innovation Bill a step closer in UK

A new bill proposed by Conservative peer Lord Saatchi has been given government backing as it seeks to become law in England. The Medicine Innovation Bill is set to allow some terminal patients, such as those dying of cancer, to be voluntarily treated with unlicensed drugs in the hope this may help their prognosis. The Bill has now been amended to require doctors to get the agreement of another sp...

Pharmacists could save the NHS £1.1 billion

New research from the Royal Pharmaceutical Society shows that common ailments such as coughs and sore throats cost the NHS an extra £1.1 billion a year when patients are treated at A&E or GP surgeries – rather than at community pharmacies. Results were equally good regardless of whether patients were treated at a pharmacy, A&E or GP practice according to the research, but the cost of tr...

Transferring Viscous or Tactile Samples?

RAININ's New LR Low Retention Pipette Tips Can Help Now available from Anachem the new LR Low Retention pipette tips improve pipetting accuracy by minimising residual volume. These tips prevent samples from interacting with the polypropylene surface of the tip, making them especially useful when transferring complex sample liquids, viscous liquids and those with reduced surface tension due to the...

Magnetic Susceptibility Balances from Sherwood Scientific Ltd

Sherwood Scientific's Magnetic Susceptibility Balances are used to quantifying magnetic properties of gases, liquids and solids Sherwood’s Magnetic Susceptibility Balances have been a fixture in Inorganic Chemistry laboratories for over 30 years and are established in hundreds of teaching and research laboratories throughout the world.  Ownership gives you and your research group the op...

Compact Recirculating Coolers by JULABO

The F series by JULABO offers space-saving and eco-friendly recirculating coolers for simple cooling applications from -10 °C to +40 °C. The F series of Compact-Recirculating coolers by JULABO are ideal for simple cooling tasks in laboratories and industry. The smallest recirculating cooler of this new family – the F250 – was technically up-graded to provide a wider temperature...

INiTS-Awards für MedUni-Wien-ForscherInnen

WissenschafterInnen der MedUni Wien gehörten beim zehnjährigen Jubiläum der INiTS-Awards zu den PreisträgerInnen. Diese Preise werden für innovative wissenschaftliche Arbeiten vergeben. Die Preise wurden in den Kategorien „Informations- und Ko...

World’s first mobile SEM

Meet world’s first Mobile SEM - the Phenom desktop SEM. A fully integrated and accredited scanning electron microscope (SEM) with EDX to be used on every location for fast and accurate investigations and analysis. The Phenom ProX is the ultimate all-in-one imaging and X-ray analysis system (EDX). With the Phenom ProX desktop SEM, sample structures can be physically examined and their element...

First GMP-Compliant Batch of a Biologic Drug Substance from a Moss Expression System Produced for Clinical Use

greenovation Biotech GmbH and BIOMEVA GmbH announced today the successful production of the world's first GMP (Good Manufacturing Practice)-compliant batch of drug substance manufactured in moss for clinical use. The drug substance, greenovation's pilot candidate Moss-aGal (recombinant human alpha-galactosidase), is planned to be used for clinical testing as a new generation of enzyme replacement...

Saturday 18th October 2014

WHO response to Internal Ebola document leaked to media

A WHO internal document recently obtained by some media outlets was the first draft of a small team documenting the chronology of the Ebola outbreak events for future review. This document has not yet been fact-checked or reviewed by WHO staff involved in the initial response to Ebola, and is part of an on-going analysis of our response. WHO will not do interviews or explain details on this docum...

WHO tobacco treaty makes significant progress despite mounting pressure from tobacco industry

The sixth session of the Conference of the parties (COP6) to the WHO Framework Convention on Tobacco Control (FCTC) concluded today in Moscow. Several landmark decisions were adopted in the course of the six-day session, regarded as one of the most successful in the WHO FCTC’s history. In her opening speech, WHO Director-General Dr Margaret Chan said that “as implementation of the Framework C...

Friday 17th October 2014

Rapid agent restores pleasure-seeking ahead of other antidepressant action

Depression deconstructed – NIH study.

GSK: Ebola vaccines will come ‘too late’

GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the company said that trials would begin soon, with the vaccine rolled-out by 2015 if everything went to plan. But today in a TV and radio interview with the BBC, Dr Ripley Ballou who is the head of GSK's Ebola vaccine research says that it will ‘well into 2016...

BioVale to develop Yorkshire and the Humber’s bioeconomy, with the help of major investments

BioVale has secured over £10m of investment to help develop the region as an international centre for bioeconomy innovation and development. The funding will be used to provide dedicated office and laboratory facilities and specialised training...

Generics and biosimilars contribute to European drug savings

As governments around the world try to rein in healthcare expenses, generics and biosimilars can play a major role in reducing this budgetary burden [1].

Mobilization of stem cells by biosimilar Nivestim and Neupogen

Comparison of biosimilar granulocyte colony-stimulating factor (G-CSF), Nivestim and originator G-CSF, Neupogen (filgrastim), showed no statistical differences when used for the mobilization of peripheral blood stem cells in patients treated for haem...

Reference pricing and generics in Finland

Reference pricing and the extension of generics substitution have produced substantial savings in antipsychotic medication costs in Finland. The daily cost of treatment with clozapine, risperidone, olanzapine or quetiapine was cut by at least a third...

Stada in-licenses teriparatide biosimilar

German generics giant Stada Arzneimittel (Stada) announced on 13 October 2014 that it had made a deal to in-licensing a teriparatide biosimilar.

French generics association promotes biosimilars

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Canada bans imports from three API facilities in India

Just days after Canada’s regulatory agency was reported to be in talks with the US Food and Drug Administration (FDA) about Canadian generics maker Apotex, Health Canada has announced that it is to ban imports from two of Apotex’s facilities and ...

Generics maker IGI Labs gains rights to AstraZeneca injectables

Speciality topical generics maker IGI Laboratories (IGI Labs) announced on 25 September 2014 that it had acquired the rights for 18 drugs from AstraZeneca.

Implications of Canadian–European Trade Agreement for generics

On 26 September 2014, Canada and the European Union (EU) successfully concluded negotiations on a trade deal, which will free the movement of goods, services, investment and labour between the two regions. However, some of the provisions in the agree...


Search BioPortfolio:
Loading
Advertisement
Advertisement